EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core. The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user. Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Douglas Connect (6 days ago)
RT @eNanoMapper: Protégé 5.2.0 released https://t.co/TGg7V4e03v (our tutorial on how to use it for our ontology: https://t.co/Dv00XOzyyB)
Douglas Connect (6 days ago)
RT @barryhardy: Obtain introduction on YouTube to #OpenTox #Garuda #DataAnalysis #2017SOT #ToxExpo @SOToxicology @DouglasConn 2160 https://…
Douglas Connect (2 weeks ago)
Please note that the early-bird/bursary deadlines (31 March) for the #eChemInfo workshop are approaching quickly: https://t.co/NxBAmGIFtz
Douglas Connect (2 weeks ago)
RT @PLOSCompBiol: PathVisio 3: An Extendable Pathway Analysis Toolbox, from Kutmon et al. https://t.co/s4onP5KT2P #SoftwareWednesdays https…
Douglas Connect (2 weeks ago)
RT @ACEnanoH2020: Our website has been officially launched! Check https://t.co/aRNgkYS4GL to be up to date of ACEnano progress. Wish you li…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com